Abstract
“...technological advances driving the science of induced pluripotency will be increasingly essential for realizing the opportunities of patient-specific, cell-based treatments, thereby translating the discoveries of today into the practice of tomorrow.” Timothy J Nelson Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA Andre Terzic Author for correspondence: Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA Tel.: +1 507 284 5514; Fax: +1 507 266 9936; E-mail: terzic.andre@ mayo.edu Induced pluripotent stem cells: reprogrammed without a trace
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
